...angles in that space.”Israeli firm aMoon and Hitachi...
...million, according to BioCentury’s BCIQ database.Camblong said Hitachi...
...into how the genomics data sector is evolving. Hitachi’s...

...was CBO of Serina Therapeutics Inc. (Huntsville, Ala.). Bitar was global head of quality at Hitachi...

...in the U.S. Monteith was COO and site general manager for three manufacturing facilities at Hitachi...

...Ray Dupuis CFO. He was CFO at Seccuris, an information technology security company acquired by Hitachi...

...and develop small molecules that regulate for circadian rhythm-related disorders. 07/24/2015 Sumitomo Dainippon Pharma Co. Ltd.(Tokyo:4506)Hitachi Ltd....
...University's CiRA is conducting preclinical research on dopaminergic neural progenitor cells produced by Sumitomo and Hitachi...

...Hitachi Chemical partnered to develop PCT’s cell therapy technology. PCT also granted manufacturing rights to Hitachi...
...other undisclosed Asian countries. PCT will receive $5.6 million in upfront and near-term milestone payments. Hitachi...
...and Hitachi Chemical did not respond to inquiries. Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Hitachi...

...Sumitomo, the university’s center for induced pluripotent stem (iPS) cell research and application (CiRA) and Hitachi...
...work with Hitachi to evaluate the validity of processing methods for automatic cell culturing equipment. Hitachi...
...and Kyoto did not respond to inquiries. Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Hitachi Ltd....

...2014-09-04 Type: Venture financing Raised: EUR64.5 million ($84.7 million) Investors: Johnson & Johnson Development Corp.; Hitachi...

...the venture arm of Johnson & Johnson (NYSE:JNJ); and PMV Tina Fund and new investor Hitachi...

...DNA sequencing company Base4 and medical systems manufacturer Hitachi partnered to develop a long read-length, single-molecule...
...three years. The partners declined to disclose financial terms. Base4 Innovation Ltd. , Cambridge, U.K. Hitachi...